Intra Nasal Sufentanil Versus Intravenous Morphine for Acute Severe Traumatic Pain Analgesia in Emergency Setting — ALGOFINE-2  

Numeric Pain Rating Scale > 5 / 10 Clinical Trial

Official title: Intra Nasal Sufentanil Versus Intravenous Morphine for Acute Severe Traumatic Pain Analgesia in Emergency Setting. A Multicenter,Randomized,Controled, Comparative, Double Blinded Study

Status Completed

Clinical Trial Summary

Intranasal (IN) administration of opiates is an appealing non-invasive way of treating acute traumatic pain in prehospital and Emergency departments (ED).

The investigators hypothesize that IN administration of Sufentanil is equal as compared with Intra veinous (IV) administration of Morphine wich is widely recommended in ED.

The investigators study is a multicentric, comparative, randomized, double-blind, double-placebo study, comparing quality of analgesia in both groups 30 minutes after first administration of opiates.

The investigators also asses side effects and patient satisfaction in both groups.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Emergencies
• Numeric Pain Rating Scale > 5 / 10
• Severe Traumatic Pain

• NCT number: NCT02095366
• Study type: Interventional
• Source: University Hospital, Grenoble
• Status: Completed
• Phase: Phase 4
• Start date: August 2, 2013
• Completion date: June 30, 2016